SUPNSupernus Pharmaceuticals

Median target
$65
calls from the last 12 months
Implied return
+51.4%
median target vs. price
Coverage
7 analysts · 7 calls
updated in the last 12 months
Consensus
6/1/0+6 net
Buy / Hold / Sell

Which analysts are behind SUPN's consensus?

See every current rating, price target and the analysts' track records for Supernus Pharmaceuticals — plus the full analyst rankings, firm analytics and screener.

The consensus above reflects 7 analysts with calls on SUPN updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

SUPN elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)

DateSourceWhoActionDetailAmount
2026-05-15ExecutiveTrump, Donald JPresidentSaleSupernus Pharmaceuticals, Inc.$15,001 - $50,000
2026-03-03CongressGilbert CisnerosCA-CA39Purchasesince trade -23.0%, vs market -35.3%$1K–$15K
2025-12-11CongressGilbert CisnerosCA-CA39Purchasesince trade -9.7%, vs market -20.8%$1K–$15K
2025-10-09CongressGilbert CisnerosCA-CA39Salesince trade -15.2%, vs market +29.3%$1K–$15K
2025-07-31ExecutiveTrump, Donald JPresidentPurchaseSupernus Pharmaceuticals, Inc.$15,001 - $500,007
2025-06-30ExecutiveTrump, Donald JPresidentSaleSupernus Pharmaceuticals, Inc.$1,001 - $150,006
2025-05-15ExecutiveTrump, Donald JPresidentPurchaseSupernus Pharmaceuticals, Inc.$15,001 - $500,005
2025-04-29ExecutiveTrump, Donald JPresidentPurchaseSupernus Pharmaceuticals, Inc.$1,001 - $150,004
2025-04-28ExecutiveTrump, Donald JPresidentPurchaseSupernus Pharmaceuticals, Inc.$15,001 - $500,004
2025-03-27ExecutiveTrump, Donald JPresidentSaleSupernus Pharmaceuticals, Inc.$15,001 - $500,003

More: congressional trades on SUPN · insider activity · executive branch · trending